Biofarm Ends H1/2026 With 46% Lower Net Profit, 15% Lower Sales Income

today, 20:36 By Ecaterina Craciun

Drug and supplement producer Biofarm (stock symbol: BIO), which was recently acquired by Polish group Polpharma for RON1.3 billion, had a net profit of RON26.4 million in January-June 2026, down 46% year-over-year, as per the company's half-yearly financial report sent to the Bucharest Stock Exchange on August 14.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
Biofarm
, earnings